Qu, T., Manev, R. and Manev, H., 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early and late onset Alzheimer’s disease, The Journal of Neuropsychiatry and Clinical Neurosciences 13 (2001) 304-305

Tingyu Qu, MD, PhD

Research Assistant Professor at Dept of PsychiatryAdjunct Assistant Professor at Dept of Anatomy and Cell Biology

Dr. Qu’s research is focused on the therapeutic potential of human stem cells (hSCs), including human fetal and adult stem cells in Alzheimer’s (AD), Parkinson’s (PD), stroke, and spinal cord injury. The ultimate goal is to develop therapeutic strategies for these currently incurable CNS diseases by using stem cell-based therapies. Dr. Qu is also an active researcher in persistent and intractable chronic pain treatment by reprogrammed stem cells. He is a Visiting Scientist and Consultant for stem cell reprogramming at the Cleveland Clinic (2009), and Grant Reviewer of Alzheimer’s Association (2003-2009).